IP
53
3
EIX
61
8
ILMN
31
4
GOOG
77
14
PNW
55
3
STT
48
4
NEE
39
9
SO
48
6
JWN
72
9
XYL
29
4
SYK
50
4
HPQ
55
3
ROK
46
3
BLK
46
2
MTCH
62
22
SLB
41
2
SLG
37
6
IRM
33
5
GE
60
5
MKC
54
3
IP
53
3
EIX
61
8
ILMN
31
4
GOOG
77
14
PNW
55
3
STT
48
4
NEE
39
9
SO
48
6
JWN
72
9
XYL
29
4
SYK
50
4
HPQ
55
3
ROK
46
3
BLK
46
2
MTCH
62
22
SLB
41
2
SLG
37
6
IRM
33
5
GE
60
5
MKC
54
3
Financhill
Back

Blueprint Medicines Vs. Nukkleus Industry Stock Comparison

Sell
40

BPMC
Blueprint Medicines

Last Price:
$90.24
Seasonality Move:
2.18%
Sell
46

NUKK
Nukkleus

Last Price:
$40.15
Seasonality Move:
-21.57%
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $90.19. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $90.19
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $40.00
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 42.23 Sell
Chaikin Money Flow: 540770 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (91.73 - 96.57) Sell
Bollinger Bands (100): (87.46 - 96.54) Sell

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.69 Buy
Relative Strength Index (14 RSI): 77.28 Buy
Chaikin Money Flow: -1366926 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.5 - 22.6) Buy
Bollinger Bands (100): (-4.22 - 11.5) Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.88 Sell
20-day SMA: 94.44 Sell
50-day SMA: 92.37 Sell
200-day SMA: 96.72 Sell
8-day EMA: 92.45 Sell
20-day EMA: 93.6 Sell
50-day EMA: 93.36 Sell
200-day EMA: 91.74 Sell

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.07 Buy
20-day SMA: 9 Buy
50-day SMA: 4.99 Buy
200-day SMA: 4.78 Buy
8-day EMA: 26.51 Buy
20-day EMA: 14.21 Buy
50-day EMA: 7.47 Buy
200-day EMA: 11.77 Buy

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.57 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):